Gene genies: Oxford Biomedica and Homology Medicines create AAV business
Gene luminaries Oxford Biomedica reach agreement with Homology Medicines to develop super group
Read MoreGene luminaries Oxford Biomedica reach agreement with Homology Medicines to develop super group
Read MoreCollaboration of big hitters and introduction of innovation sparks pioneering HIV vaccination trial
Read MoreVir Biotech has launched a new antibody research initiative, expanding its partnership with the Bill & Melinda Gates Foundation
Read MoreDjokovic drama causes a racket: so how would the UK respond?
Read MoreIn October 2021, over 356,000 people in England had been waiting for over six weeks for a key diagnostic test
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
